TherapeuticsMD, Inc.: 10-Q filed 2012-08-09
What TherapeuticsMD, Inc. reported in its quarterly report filed 2012-08-09 (fiscal Q2 2012): 32 published measures, 84 facts as tagged in accession 0001387131-12-002558.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-08-09
- Fiscal period
- fiscal Q2 2012
- Accession
- 0001387131-12-002558 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TherapeuticsMD, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 4,877,741 | USD | |
| At 2011-12-31 | 1,438,721 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 5,582,146 | USD | |
| At 2011-12-31 | 3,150,579 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -704,405 | USD | |
| At 2011-12-31 | -1,711,858 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,327,013 | USD | |
| At 2011-12-31 | 126,421 | USD | |
| At 2011-06-30 | 78,255 | USD | |
| At 2010-12-31 | 422,939 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -11,850,038 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -25,139,641 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -1,066,381 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,840,746 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -5,248,783 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -1,562,519 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 66,404 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 25,953 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 6,965,619 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 1,504,455 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -516,244 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -286,620 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -42,132,719 | USD | |
| At 2011-12-31 | -16,993,078 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 107,405 | USD | |
| At 2011-12-31 | 70,113 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 529,129 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 98,236 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -3,974,582 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -6,842,603 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -1,050,814 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,822,255 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 3,454,993 | USD | |
| At 2011-12-31 | 1,237,274 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 92,777 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 141,458 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 232 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 232 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 2,487,943 | USD | |
| At 2011-12-31 | 3,150,579 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 692,132 | USD | |
| At 2011-12-31 | 306,511 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 407,929 | USD | |
| At 2011-12-31 | 26,720 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 4,421,362 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 7,674,951 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 1,320,141 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,373,682 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 820,241 | USD | |
| At 2011-12-31 | 588,073 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 446,780 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 832,348 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 269,327 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 551,427 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 3,573,485 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 6,400,535 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 1,200,411 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,185,530 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 833,342 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,245,303 | USD | 182 |
| 2011-04-01 to 2011-06-30 | 106,019 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 160,730 | USD | 181 |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -110,612 | USD | |
| At 2011-12-31 | -81,500 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,215,340 | USD | |
| At 2011-12-31 | 80,515 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -11,850,038 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -25,139,641 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -1,066,381 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -1,840,746 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 29,113 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 27,422 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 29,113 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 27,422 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -7,875,456 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -18,297,038 | USD | 182 |
| 2011-04-01 to 2011-06-30 | -15,567 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -18,491 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -396,232 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -20,969 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -232,168 | USD | 182 |
| 2011-01-01 to 2011-06-30 | -574 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 385,620 | USD | 182 |
| 2011-01-01 to 2011-06-30 | 113,624 | USD | 181 |
Inspect the source
- Entity
- TherapeuticsMD, Inc. / CIK 0000025743
- Captured
- 2026-09-19T14:45:35.881Z
- SEC response SHA-256
566f636dfc852372b704143e2678a66d8d716f0795f8652994459dcc9f22859d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000025743.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))